{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-250611","form_type":"8-K","ticker":"PHAT","cik":"0001783183","company_name":"Phathom Pharmaceuticals, Inc.","filed_at":"2025-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.440428+00:00","generated_at":"2026-05-17T02:12:34.723455+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Phathom publishes Phase 3 NERD data showing VOQUEZNA improves nocturnal GERD symptoms","bullets":["At week 4, VOQUEZNA 10 mg and 20 mg achieved 59.9% and 56.4% heartburn-free nights vs 43.3% placebo (nominal p<0.0001).","Median heartburn-free nights: 70.4% (10 mg), 71.0% (20 mg), 45.5% (placebo) over 4 weeks.","Separation from placebo observed after first dose: 45.3% (10 mg) and 52.4% (20 mg) heartburn-free night vs 32.1% placebo.","Symptom relief sustained through 20-week active extension; median heartburn-free nights remained above 70%.","VOQUEZNA generally well tolerated; most common AEs (≤5%) included URI, sinusitis, influenza, UTI, nausea."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-250611","json":"https://secwatch.observer/filing/0001193125-25-250611.json","markdown":"https://secwatch.observer/filing/0001193125-25-250611.md","text":"https://secwatch.observer/filing/0001193125-25-250611.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783183/000119312525250611/0001193125-25-250611-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783183/000119312525250611/d62248d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:12:34.723455+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}